Skip to Content
 

News: February, 2021

Convalescent plasma improved survival in COVID-19 patients with blood cancers

Friday, February 5th, 2021

Treatment with convalescent plasma vastly improved the survival rate of patients hospitalized for COVID-19 who also had hematologic malignances that compromise the immune system, according to new data released by the COVID-19 and Cancer Consortium (CCC19).

Potential biomarker for IBD severity, cancer risk identified

Thursday, February 4th, 2021

A selenium transport protein produced in the colon is underexpressed in patients with ulcerative colitis and helps protect against colitis-associated cancer in an animal model, Vanderbilt investigators have discovered.

Gene network for leukemia factor

Thursday, February 4th, 2021

Transcription factors — proteins that regulate gene expression — play critical roles in cell fate decisions and are frequent targets of mutation in a variety of human cancers.